BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/21/2026 7:18:35 AM | Browse: 7 | Download: 0
Publication Name World Journal of Cardiology
Manuscript ID 120433
Country China
Category Cardiac & Cardiovascular Systems
Manuscript Type Editorial
Article Title Landiolol and septic ventricular arrhythmias: Revisiting the inflammation–fibrosis–Nav1.5/Cx43 electro-structural axis
Manuscript Source Invited Manuscript
All Author List Jiao Tang, Xue Deng, Ting Luo, Zhuoma Gesang, Zi-Ran Jia, Quzhun Danzeng and Tao Wang
Funding Agency and Grant Number
Funding Agency Grant Number
Xizang Autonomous Region Science and Technology Program XZ202501YD0006
Medical Science Research Project of Sichuan Province S23014
Corresponding Author Tao Wang, Chief Physician, MD, Department of Pediatrics, West China Second University Hospital, Sichuan University, No. 20 South Renmin Road, Chengdu 610041, Sichuan Province, China. 44871875@qq.com
Key Words Sepsis; Ventricular arrhythmia; Landiolol; β1 blocker; Cx43; Nav1.5; Conduction dispersion; Fibrosis; Electro structural remodeling; Precision critical care
Core Tip Hu et al demonstrated that landiolol reduced ventricular arrhythmia burden in a septic rat model while attenuating inflammation, apoptosis, and fibrosis, improving conduction heterogeneity, and being accompanied by reciprocal changes in Cx43 and Nav1.5 expression. The key message is conceptual rather than definitive: Ultra-short-acting beta1 blockade may benefit selected septic patients by modulating an inflammation-fibrosis-Nav1.5/Cx43 electro-structural axis, not merely by slowing heart rate. Future studies should explicitly link expression to function through INa and gap-junction or hemichannel assays, define the safe dose and time window, and translate this framework through phenotype-guided clinical implementation.
Citation Tang J, Deng X, Luo T, Gesang Z, Jia ZR, Danzeng Q, Wang T. Landiolol and septic ventricular arrhythmias: Revisiting the inflammation–fibrosis–Nav1.5/Cx43 electro-structural axis. World J Cardiol 2026; In press
Received
2026-02-27 03:26
Peer-Review Started
2026-02-27 03:26
First Decision by Editorial Office Director
2026-03-09 08:54
Return for Revision
2026-03-09 08:54
Revised
2026-03-22 20:56
Publication Fee Transferred
Second Decision by Editor
2026-04-21 02:51
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-21 07:18
Articles in Press
2026-04-21 07:18
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1949-8462 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com